Abnormal expression of Nrf2 may play an important role in the pathogenesis and development of adenomyosis

Ning Chen1, Baoying Du1, Hao Zhou2

  • 1Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.

Plos One
|August 18, 2017
PubMed
Abstract

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) protein is upregulated in adenomyosis, promoting endometrial cell migration and MMP9 expression. Targeting Nrf2 offers a potential therapeutic strategy for adenomyosis.

Area of Science:

  • Gynecology
  • Cell Biology
  • Molecular Medicine

Background:

  • Adenomyosis is a benign gynecological condition characterized by endometrial gland and stroma infiltration into the myometrium.
  • The underlying molecular mechanisms of adenomyosis pathogenesis remain incompletely understood.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular defense against oxidative stress.

Purpose of the Study:

  • To investigate the expression levels of Nrf2 in adenomyosis tissues.
  • To elucidate the role of Nrf2 in the pathogenesis and cellular behavior of adenomyosis.
  • To explore the potential of Nrf2 as a therapeutic target for adenomyosis.

Main Methods:

  • Western blot and immunohistochemistry (IHC) were employed to quantify Nrf2 protein levels in tissue samples.
  • Real-time PCR was utilized to assess Nrf2 mRNA expression.
  • In vitro experiments involved Nrf2 knockdown and overexpression in primary endometrial glandular cells to evaluate migration and MMP9 expression.

Main Results:

  • Nrf2 protein levels were significantly elevated in both eutopic and ectopic endometrial glands of adenomyosis patients compared to controls.
  • No significant difference in Nrf2 mRNA levels was observed between adenomyosis and control groups.
  • Modulating Nrf2 protein levels in cultured cells affected cell migration and matrix metalloproteinase 9 (MMP9) expression, with higher Nrf2 correlating with increased migration and MMP9 levels.

Conclusions:

  • Abnormal Nrf2 protein expression is implicated in the pathogenesis and progression of adenomyosis.
  • Nrf2 influences the migratory capacity of endometrial glandular cells, potentially via MMP9 regulation.
  • Targeting Nrf2, specifically by reducing its expression, presents a promising therapeutic avenue for adenomyosis treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.3K